ArticleFrontiers in pharmacology2025
Jaranol: a compound with therapeutic activity against pathological cardiac remodelling via multi-target inhibition of the Snai3/TLR2 and NF-κB signaling pathways.
Yao Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.